Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3707630013 | Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3707631012 | Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form | Is a | Neomycin-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form | Has active ingredient | Nystatin | true | Inferred relationship | Some | 2 | |
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form | Is a | Clobetasol-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form | Is a | Nystatin-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form | Has active ingredient | Clobetasol | true | Inferred relationship | Some | 3 | |
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Some | ||
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form | Has active ingredient | Neomycin | true | Inferred relationship | Some | 1 | |
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form | Is a | Clobetasol- and neomycin- and nystatin-containing product | true | Inferred relationship | Some | ||
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some | ||
Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form | Plays role | Antifungal therapeutic role | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Clobetasol and neomycin and nystatin only product in cutaneous dose form | Is a | True | Clobetasol- and neomycin- and nystatin-containing product in cutaneous dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set